Area of research
Molecular Biology · Immunology
Research interest
Research interests include RNA modifications and cancer, T-cell and Retrovirus Studies, Epigenetics and DNA Methylation, and Cancer-related gene regulation.
ASB7 is a negative regulator of H3K9me3 homeostasis
Beyond the Secretory Pathway: New Insights Into Protein Release
Activated STING-containing R-EVs from iPSC-derived MSCs promote antitumor immunity
Disrupting the phase separation of KAT8–IRF1 diminishes PD-L1 expression and promotes antitumor immunity
Mitochondria-ER contact mediated by MFN2-SERCA2 interaction supports CD8 <sup>+</sup> T cell metabolic fitness and function in tumors
Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance
Activating STING/TBK1 suppresses tumor growth via degrading HPV16/18 E7 oncoproteins in cervical cancer
G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC‐I via PI3K/Akt Activation in Bladder Cancer
MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria‐dependent dephosphorylation of EGFR
Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Intercellular transfer of activated STING triggered by RAB22A-mediated non-canonical autophagy promotes antitumor immunity
Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2
Carbonic anhydrase XII mediates the survival and prometastatic functions of macrophages in human hepatocellular carcinoma
DOAJ (DOAJ: Directory of Open Access Journals) 2022cited by 52position: middle
RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer
Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer
Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors
RAB31 marks and controls an ESCRT-independent exosome pathway
NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma
KIF2C: a novel link between Wnt/β-catenin and mTORC1 signaling in the pathogenesis of hepatocellular carcinoma
Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma
A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma
A gene-expression-based signature predicts survival in adults with T-cell lymphoblastic lymphoma: a multicenter study
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
Up-regulation of PCOLCE by TWIST1 promotes metastasis in Osteosarcoma
Lkb1 deletion in periosteal mesenchymal progenitors induces osteogenic tumors through mTORC1 activation
YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma